Los Angeles, Feb. 16, 2016 -- Celebrity liposuction expert and lipedema treatment pioneer Dr. David Amron announces the launch of the Anti-Aging & Regenerative programs at The Roxbury Institute in Beverly Hills, California. To kick off the educational series, the first-of-its-kind aesthetics and anti-aging facility will be hosting world-renowned orthopedic surgeon Dr. Michael Price for a rare discussion on non-surgical solutions for joint pain, tonight at 7:00 p.m.
Focused on targeted comprehensive care, The Roxbury Institute features specialists and sub-specialists in nearly every area of aesthetics and anti-aging medicine, including facial and body plastic surgery, high definition body contouring, dermatology, fat transfer, and more. Additionally, it’s highly trusted Anti-Aging Center is home to the foremost experts in hormone replacement, gut health, IV nutrition, stem cell therapy, and nutraceuticals.
“We are extremely enthusiastic about our premier Anti-Aging & Regenerative program at the institute,” said Dr. Amron, founder of The Roxbury Institute. “Chronic joint pain is a prevalent issue affecting thousands of individuals, and Dr. Price is at the forefront of both surgical and non-surgical solutions to the issue.”
Dr. Price will be showcasing the institute’s new FDA-approved cell therapy treatment for degenerative joint conditions. The educational event will be open to all current and potential patients of The Roxbury Institute.
“We’ve built this institute on the unique philosophy that aesthetic care should go hand-in-hand with internal consideration,” said Dr. Amron. “In hosting these educational discussions, we hope to empower patients to always make the best possible choices when it comes to both their aesthetic and internal health concerns.”
The Roxbury Institute is located at 450 North Roxbury Drive, Suite #400 in Beverly Hills, California. For more information or to schedule an appointment, please visit http://www.theroxburyinstitute.com/
Bailey Potter 323.937.1951 [email protected]


Washington Post Publisher Will Lewis Steps Down After Layoffs
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



